Pure Global

KIT DE DIAGNÓSTICO IN VITRO PARA ÁCIDO NUCLEICO DE CORONAVIRUS DEL SARS-COV- 2 - COFEPRIS Registration 0774R2024 SSA

Access comprehensive regulatory information for KIT DE DIAGNÓSTICO IN VITRO PARA ÁCIDO NUCLEICO DE CORONAVIRUS DEL SARS-COV- 2 (KIT DE DIAGNÓSTICO IN VITRO PARA ÁCIDO NUCLEICO DE CORONAVIRUS DEL SARS-COV- 2) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 0774R2024 SSA and manufactured by ABALAT, S.A. DE C.V.. The device was registered on March 22, 2024.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
0774R2024 SSA
KIT DE DIAGNÓSTICO IN VITRO PARA ÁCIDO NUCLEICO DE CORONAVIRUS DEL SARS-COV- 2
COFEPRIS Analysis ID: 0774R2024 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
GENEFINDER COVID-19 PLUS REALAMP KIT
Trade Name (English)
GENEFINDER COVID-19 PLUS REALAMP KIT
Registration Information
Analysis ID
0774R2024 SSA
Registration Date
March 22, 2024
Manufacturer / Fabricante
Name (Spanish)
ABALAT, S.A. DE C.V.
Name (English)
ABALAT, S.A. DE C.V.